Author:
Remon Jordi,Hendriks Lizza E.L.,Mountzios Giannis,García-Campelo Rosario,Saw Stephanie P.L.,Uprety Dipesh,Recondo Gonzalo,Villacampa Guillermo,Reck Martin
Subject
Pulmonary and Respiratory Medicine,Oncology
Reference122 articles.
1. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors;Frampton;Cancer Discov,2015
2. MET Exon 14 skipping mutations in non-small-cell lung cancer: an overview of biology, clinical outcomes, and testing considerations;Socinski;JCO Precis Oncol,2021
3. MET Exon 14 mutations in non-small-cell lung cancer are associated with advanced age and stage-dependent MET genomic amplification and c-met overexpression;Awad;J Clin Oncol,2016
4. Characterization of non-small-cell lung cancers with MET Exon 14 skipping alterations detected in tissue or liquid: clinicogenomics and real-world treatment patterns;Lee;JCO Precis Oncol,2021
5. Landscape and clonal dominance of co-occurring genomic alterations in non-small-cell lung cancer harboring MET Exon 14 skipping;Le;JCO Precis Oncol,2021
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献